Regulatory Impact Assessment

You’re expanding into a new market. You need to know what the regulatory environment actually means for your product — not a list of laws, but a clear picture of what applies, what’s changing, and what it means for how you enter, partner, and deploy.

What it is

A Regulatory Impact Assessment (RIA) from HealthTechAsia is a structured, market-specific analysis of how current and upcoming regulations affect your deployment model, partnership structure, and operational design.

We go beyond the statute. We interpret the regulatory environment in context — drawing on our editorial relationships with regulators, policymakers, and health system leaders across ASEAN and the Middle East to give you a picture that reflects how policy actually operates on the ground.

What you get

• A written assessment of the regulatory landscape as it applies to your product category and market entry model
• Analysis of upcoming policy changes and their likely operational implications
• Identification of key approval pathways, data residency requirements, and partnership constraints
• Practical recommendations on sequencing, risk areas, and where to engage early
• Delivered as a professionally formatted PDF brief — typically 8–15 pages

Who this is for

Health AI companies, digital health platforms, and MedTech firms preparing to enter or expand in ASEAN or the Gulf — particularly those navigating SaMD classifications, health data regulations, or AI-specific governance requirements for the first time.

To get started

Send a brief note to team@healthtechasia.co with the market you’re entering and a short description of your product or service. We’ll confirm scope and availability within two business days.